C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2011
11/23/2011	CN102250214A Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy
11/23/2011	CN102250213A Matrix metalloproteinase-9 polypeptide inhibitor 3 and application thereof
11/23/2011	CN102250212A Matrix metalloproteinase-9 polypeptide inhibitor 5 and use thereof
11/23/2011	CN102250211A HLA-A*3303-Restricted WT1 Peptide and pharmaceutical composition comprising the same
11/23/2011	CN102250210A Human plasminogen Kringle 5 short peptide, its pharmaceutical composition, application and polynucleotide encoding the short peptide
11/23/2011	CN102250209A Novel HLA-A2 (Human Leukocyte Antigen-Alpha2) restrictive epitope polypeptide and application thereof
11/23/2011	CN102250208A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011	CN102250207A Novel human leukocyte antigen (HLA)-A2 limiting epitope polypeptide and use thereof
11/23/2011	CN102250206A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011	CN102250204A RGD sequence peptidyl methyl curcumin compounds, preparation method thereof, and application thereof
11/23/2011	CN101538318B Signal peptide, coding genes thereof and application
11/23/2011	CN101497655B Polypeptide hydration salt compound and use for anti-depression aspect
11/22/2011	US8063263 Methods for the treatment or prevention of scars and/or keloids
11/22/2011	US8063181 Method for the production of cyclic molecules
11/22/2011	US8063180 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
11/22/2011	US8063179 Carbon nanotube binding peptides
11/22/2011	US8063106 ApoE mimetic agents
11/22/2011	US8062906 B-lymphocyte stimulator binding polypeptides and methods based thereon
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2444278C Modified cyclosporine which can be used as a pro-drug and use thereof
11/22/2011	CA2257826C Helicobacter pylori adhesin binding group antigen
11/17/2011	WO2011141658A1 Peptides with antiprotease activity
11/17/2011	US20110282030 Naturiuretic polypeptides
11/17/2011	US20110282029 Novel peptides that bind to the erythropoietin receptor
11/17/2011	US20110281805 Use of an ang-(1-7) receptor agonist in acute lung injury
11/17/2011	US20110281804 Peptidic and peptidomimetic compounds for regulating autophagy
11/17/2011	US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011	US20110281290 Sox-based kinase sensor
11/17/2011	US20110280920 Peptides and compositions for prevention of cell adhesion and methods of using same
11/17/2011	US20110280899 Novel Immunogenic Lipopeptides Comprising T-Helper And Cytotoxic T-Lymphocyte (CTL) Epitopes
11/17/2011	US20110280898 Inhbb epitope peptides and vaccines containing the same
11/17/2011	US20110280897 Polypeptides and uses thereof
11/17/2011	US20110280896 Methods and compositions for tumor vaccination and therapy
11/17/2011	US20110280889 High affinity t cell receptor and use thereof
11/17/2011	US20110280802 Linkers For Radiopharmaceutical Compounds
11/17/2011	US20110280798 Cell Penetrating Peptides for Intracellular Delivery
11/16/2011	EP2386566A2 Chi-conotoxin peptides (II)
11/16/2011	EP2103630B1 Preparation of low bleeding anticoagulant fusion protein and its use
11/16/2011	EP1765851B1 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification
11/16/2011	EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
11/16/2011	CN102245637A Antibody against n-terminal region of beta-chain of hemoglobin
11/16/2011	CN102245636A Etoposide and doxorubicin conjugates for drug delivery
11/16/2011	CN102245635A Modified variant bowman birk protease inhibitors
11/16/2011	CN102245632A Muc-1 cytoplasmic domain peptides as inhibitors of cancer
11/16/2011	CN102245626A Mini-hepcidin peptides and methods of using thereof
11/16/2011	CN102245625A Method of making biologically active alpha-beta peptides
11/16/2011	CN102245623A Single-chain antiparallel coiled coil proteins
11/16/2011	CN102241747A Humanlike elastin and production method thereof
11/16/2011	CN102241742A Peptides and compounds that bind to a thrombopoietin receptor
11/16/2011	CN102241741A Prion protein ligands and methods of use
11/16/2011	CN102241740A Compounds with thrombolytic activities and preparation methods and applications thereof
11/16/2011	CN102241739A Peptide production and purification process
11/16/2011	CN102241738A Mimic polypeptide of non-collagen protein and application of the mimic peptide in biomimetic mineralization
11/16/2011	CN102241735A Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof
11/16/2011	CN102241732A Method for purifying lipopetide compound
11/16/2011	CN102020702B Influenza A type H3N2 virus hemagglutinin protein affinity peptide
11/16/2011	CN101891802B Polypeptide or derivative product for treating or preventing cancer and application thereof
11/16/2011	CN101838310B Basic fibroblast growth factor epitope simulative peptide T3 and application thereof
11/16/2011	CN101429234B Vaccine based on simulating human blood vessel endothelial cell growth factor VEGF epitope and preparation method thereof
11/15/2011	US8058442 Neuroprotective iron chelators and pharmaceutical compositions comprising them
11/15/2011	US8058410 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography
11/15/2011	US8058393 Microwave-assisted peptide synthesis
11/15/2011	US8058392 Carbon nanotube binding peptides
11/15/2011	US8058244 Cyclic peptide antitumor agents
11/15/2011	US8058238 High purity lipopeptides
11/15/2011	US8058068 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation
11/15/2011	US8058017 Methods and compositions for purifying human factor VIII, factor VIII-like proteins or fragments thereof
11/15/2011	US8057802 Treatment methods for fibrosis related disorders
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	CA2421791C Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
11/15/2011	CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/15/2011	CA2405715C Methods for selective targeting
11/10/2011	WO2011138757A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/10/2011	WO2011137886A1 Agents for treating alzheimer's disease
11/10/2011	WO2011113819A3 Diagnosis and treatment of cancer based on avl9
11/10/2011	WO2011084604A3 Flavivirus species-specific peptide tags for vaccine and diagnostic use
11/10/2011	WO2011084571A3 Azide derivatives for phototherapy
11/10/2011	WO2011071280A3 Intracelluar targeting bipodal peptide binder
11/10/2011	WO2011071279A3 Bpb-based cargo delivery system
11/10/2011	US20110275788 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
11/10/2011	US20110275784 Asymmetric synthesis of peptides
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275573 Tissue adhesive
11/10/2011	US20110275569 Proteases targeting agents
11/10/2011	US20110275562 Inhibition of gliadin peptides
11/10/2011	US20110275556 Treatment of atherosclerosis
11/10/2011	US20110275554 Compounds
11/10/2011	US20110275150 Compstatin analogs with improved activity
11/10/2011	US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids
11/10/2011	US20110275102 Activation of mutated rac-pk
11/10/2011	US20110274747 C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
11/10/2011	US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011	US20110274619 Brain tumor targeting peptides and methods
11/10/2011	CA2795596A1 Agents for treating alzheimer's disease
11/09/2011	EP2385117A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
11/09/2011	EP2385057A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/09/2011	CN1845920B 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11/09/2011	CN1802385B Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/09/2011	CN102234316A Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof
11/09/2011	CN102234315A Modified endomorphin-1 compound and application in easing pain thereof

1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 423